1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De SG, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger Mussolino M, Nichol VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J . Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010; 121: e46–e215.
2. Arnold JM, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A, Lonn E, Pogue J, Bosch J . Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003; 107: 1284–1290.
3. deBlois D, Tea BS, Than VD, Tremblay J, Hamet P . Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 1997; 29: 340–349.
4. Schiffrin EL, Deng LY, Larochelle P . Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients. J Cardiovasc Pharmacol 1994; 24 (Suppl 3): S51–S56.
5. Der Sarkissian S, Marchand EL, Duguay D, Hamet P, deBlois D . Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril. Cardiovasc Res 2003; 57: 775–783.